ASCCP Management Guidelines
Pautas de gestión de ASCCP: ¡hay una aplicación para eso!
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.nnASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.nnThese evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:nn• Allow for a more complete and precise estimation of riskn• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)n• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)n• Allow for the future addition of new risk modifiers and screening and management technologiesnnSee https://www.asccp.org/UserGuide for tips on using the app.
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.nnASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.nnThese evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:nn• Allow for a more complete and precise estimation of riskn• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)n• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)n• Allow for the future addition of new risk modifiers and screening and management technologiesnnSee https://www.asccp.org/UserGuide for tips on using the app.